Refining the use of cabazitaxel in metastatic castrate-resistant prostate cancer

被引:1
作者
Culine, Stephane [1 ,2 ]
机构
[1] Hop St Louis, AP HP, Dept Med Oncol, Paris, France
[2] Paris Diderot Univ, Paris, France
关键词
DOCETAXEL; MITOXANTRONE; PREDNISONE; TAXANE; TUMORS; TRIAL;
D O I
10.1016/j.ejca.2018.04.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:30 / 32
页数:3
相关论文
共 9 条
[1]   Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naive, Metastatic, Castration-Resistant Prostate Cancer [J].
Antonarakis, Emmanuel S. ;
Tagawa, Scott T. ;
Galletti, Giuseppe ;
Worroll, Daniel ;
Ballman, Karla ;
Vanhuyse, Marie ;
Sonpavde, Guru ;
North, Scott ;
Albany, Costantine ;
Tsao, Che-Kai ;
Stewart, John ;
Zaher, Atef ;
Szatrowski, Ted ;
Zhou, Wei ;
Gjyrezi, Ada ;
Tasaki, Shinsuke ;
Portella, Luigi ;
Bai, Yang ;
Lannin, Timothy B. ;
Suri, Shalu ;
Gruber, Conor N. ;
Pratt, Erica D. ;
Kirby, Brian J. ;
Eisenberger, Mario A. ;
Nanus, David M. ;
Saad, Fred ;
Giannakakou, Paraskevi .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (28) :3181-+
[2]   Safety and efficacy of 2-weekly cabazitaxel in metastatic castration-resistant prostate cancer [J].
Clement-Zhao, Alice ;
Auvray, Marie ;
Aboudagga, Hail ;
Blanc-Durand, Elix ;
Angelergues, Antoine ;
Vano, Yann Alexandre ;
Mercier, Florence ;
El Awadly, Nader ;
Verret, Benjamin ;
Thibault, Constance ;
Oudard, Stephane .
BJU INTERNATIONAL, 2018, 121 (02) :203-208
[3]   Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial [J].
de Bono, Johann Sebastian ;
Oudard, Stephane ;
Ozguroglu, Mustafa ;
Hansen, Steinbjorn ;
Machiels, Jean-Pascal ;
Kocak, Ivo ;
Gravis, Gwenaelle ;
Bodrogi, Istvan ;
Mackenzie, Mary J. ;
Shen, Liji ;
Roessner, Martin ;
Gupta, Sunil ;
Sartor, A. Oliver .
LANCET, 2010, 376 (9747) :1147-1154
[4]   Phase III Study Comparing a Reduced Dose of Cabazitaxel (20 mg/m2) and the Currently Approved Dose (25 mg/m2) in Postdocetaxel Patients With Metastatic Castration-Resistant Prostate Cancer-PROSELICA [J].
Eisenberger, Mario ;
Hardy-Bessard, Anne-Claire ;
Kim, Choung Soo ;
Geczi, Lajos ;
Ford, Daniel ;
Mourey, Loic ;
Carles, Joan ;
Parente, Phillip ;
Font, Albert ;
Kacso, Gabriel ;
Chadjaa, Mustapha ;
Zhang, Wenping ;
Bernard, John ;
de Bono, Johann .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (28) :3198-+
[5]   Phase I and Pharmacokinetic Study of XRP6258 (RPR 116258A), a Novel Taxane, Administered as a 1-Hour Infusion Every 3 Weeks in Patients with Advanced Solid Tumors [J].
Mita, Alain C. ;
Denis, Louis J. ;
Rowinsky, Eric K. ;
DeBono, Johann S. ;
Goetz, Andrew D. ;
Ochoa, Leonel ;
Forouzesh, Bahram ;
Beeram, Muralidhar ;
Patnaik, Amita ;
Molpus, Kathleen ;
Semiond, Dorothee ;
Besenval, Michele ;
Tolcher, Anthony W. .
CLINICAL CANCER RESEARCH, 2009, 15 (02) :723-730
[6]   Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer [J].
Tannock, IF ;
de Wit, R ;
Berry, WR ;
Horti, J ;
Pluzanska, A ;
Chi, KN ;
Oudard, S ;
Theodore, C ;
James, ND ;
Turesson, I ;
Rosenthal, MA ;
Eisenberger, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (15) :1502-1512
[7]   Efficacy of cabazitaxel rechallenge in heavily treated patients with metastatic castration-resistant prostate cancer [J].
Thibault, Constance ;
Eymard, Jean-Christophe ;
Birtle, Alison ;
Krainer, Michael ;
Baciarello, Giulia ;
Flechon, Aude ;
Le Moulec, Sylvestre ;
Spaeth, Dominique ;
Laguerre, Brigitte ;
Caffo, Orazio ;
Deville, Jean-Laurent ;
Beuzeboc, Phillipe ;
Hasbini, Ali ;
Gross-Goupil, Marine ;
Helissey, Carole ;
Bennamoun, Mostefa ;
Hardy-Bessard, Anne-Claire ;
Oudard, Stephane .
EUROPEAN JOURNAL OF CANCER, 2018, 97 :41-48
[8]   Preclinical Antitumor Activity of Cabazitaxel, a Semisynthetic Taxane Active in Taxane-Resistant Tumors [J].
Vrignaud, Patricia ;
Semiond, Dorothee ;
Lejeune, Pascale ;
Bouchard, Herve ;
Calvet, Loreley ;
Combeau, Cecile ;
Riou, Jean-Francois ;
Commercon, Alain ;
Lavelle, Francois ;
Bissery, Marie-Christine .
CLINICAL CANCER RESEARCH, 2013, 19 (11) :2973-2983
[9]  
Yachnin J, 2018, EUR J CANC